Pfizer
Maggie Tsai is currently the Chief of Staff within the Business Innovation Office at Pfizer. Maggie has over six years of experience in the pharmaceutical and healthcare industries. Prior to joining Pfizer, Ms. Tsai served as the Senior Manager of Corporate Strategic Innovation at BD from August 2013 to June 2018. In this role, they were responsible for leading BD's corporate strategic planning process and identifying new growth opportunities.
Ms. Tsai began their career in the pharma industry as an intern at BD in 2012, where they worked in strategic marketing. Maggie later joined Prognos as a Business Development Intern in 2011. In this role, they assisted with the development and launch of Prognos' first market intelligence product.
Ms. Tsai graduated from Northern Trust University with a degree in Investment Banking in 2008. Maggie is a Certified Public Accountant (CPA) and a Certified Management Accountant (CMA).
Maggie Tsai has a BA in Economics and Mathematics from Northwestern University and an MBA in Marketing, Finance, and Strategic Management from The University of Chicago Booth School of Business.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.